Talphera

Talphera, based in Redwood City, is a specialty pharmaceutical company dedicated to developing and commercializing innovative therapies for medically supervised settings. Its core products include NanoTab, an oral transmucosal tablet, and the Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system designed for acute postoperative pain management. Talphera aims to enhance patient outcomes by providing high-quality tools that offer improved cost and convenience for healthcare providers.

Talphera has made significant strides in the pharmaceutical industry with its cutting-edge pain management systems. The Sufentanil NanoTab PCA system, in particular, represents a notable advancement in patient-controlled analgesia, offering a combination of drug and device for effective pain relief. By focusing on the needs of both patients and medical teams, Talphera has positioned itself as a leader in optimizing care outcomes in hospital settings.